Inflammatory cytokines and comorbidity development in breast cancer survivors versus noncancer controls: Evidence for accelerated aging?

Journal of Clinical Oncology

Volumn 35, Issue 2, 2017, Pages 149-156

  Alfano, Catherine M ^a   Peng, Juan ^b   Andridge, Rebecca R ^c   Lindgren, Monica E ^b,c   Povoski, Stephen P ^b,c   Lipari, Adele M ^b,c   Agnese, Doreen M ^b,c   Farrar, William B ^b,c   Yee, Lisa D ^b,c   Carson, William E ^b,c   Janice, K Kiecolt Glaser ^b,c  

^a AMERICAN CANCER SOCIETY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TUMOR NECROSIS FACTOR; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVOR; CHARLSON COMORBIDITY INDEX; COMORBIDITY ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IMMUNE DYSREGULATION; INFLAMMATION; INTERVIEW; LONGITUDINAL STUDY; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; QUESTIONNAIRE; AGING, PREMATURE; BLOOD; BREAST NEOPLASMS; COMORBIDITY; COMPLICATION; CYTOKINESIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY;

AGING, PREMATURE; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMORBIDITY; CYTOKINESIS; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LONGITUDINAL STUDIES; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85009812109     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.67.1883     Document Type: Article

References (38)

1. National Cancer Institute: Surveillance, Epidemiology, and End Results Program Research Data (1973-2013). Released Apr 2016; based on Nov 2015 submission. www.seer.cancer.gov.
2. American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014-2015. Atlanta, GA, American Cancer Society, 2014.
3. Hewitt M, Greenfield S., Stovall E: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, National Academies Press, 2006.
4. Adler NE, Page A, National Institue of Medicine (US) Committee on Psychosocial Services to Cancer Patients/Families in a Community Setting: Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington, DC, National Academies Press, 2008.
5. Irwin ML, Crumley D, McTiernan A, et al: Physical activity levels before and after a diagnosis of breast carcinoma: The Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 97:1746-1757, 2003.
6. Henderson TO, Ness KK, Cohen HJ: Accelerated aging among cancer survivors: From pediatrics to geriatrics. Am Soc Clin Oncol Educ Book e423-e430, 2014.
7. Ness KK, Krull KR, Jones KE, et al: Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude Lifetime cohort study. J Clin Oncol 31: 4496-4503, 2013.
8. Schuitema I, Deprez S, Van Hecke W, et al: Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies. J Clin Oncol 31:3378-3388, 2013.
9. Bennett JA, Winters-Stone KM, Dobek J, et al: Frailty in older breast cancer survivors: Age, prevalence, and associated factors. Oncol Nurs Forum 40: E126-E134, 2013.
10. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994.
11. Nechuta S, Lu W, Zheng Y, et al: Comorbidities and breast cancer survival: A report fromthe Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 139:227-235, 2013.
12. Jordan JH, Thwin SS, Lash TL, et al: Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: A prospective-matched cohort study. Breast Cancer Res Treat 146:401-409, 2014.
13. Ahern TP, Lash TL, Thwin SS, et al: Impact of acquired comorbidities on all-cause mortality ratesamong older breast cancer survivors.Med Care 47: 73-79, 2009.
14. Nagel G, Wedding U, Rö hrig B, et al: The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 130:664-670, 2004.
15. Griffiths RI, Gleeson ML, Valderas JM, et al: Impact of undetected comorbidity on treatment and outcomes of breast cancer. Int J Breast Cancer 2014: 970780, 2014.
16. HolmesHM, Nguyen HT, Nayak P, et al: Chronic conditions and health status in older cancer survivors. Eur J Intern Med 25:374-378, 2014.
17. Smith AW, Reeve BB, Bellizzi KM, et al: Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev 29:41-56, 2008.
18. Leach CR, Weaver KE, Aziz NM, et al: The complex health profile of long-term cancer survivors: Prevalence and predictors of comorbid conditions. J Cancer Surviv 9:239-251, 2015.
19. Ló pez-Otín C, Blasco MA, Partridge L, et al: The hallmarks of aging. Cell 153:1194-1217, 2013.
20. Campisi J: Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685-705, 2013.
21. Payette H, Roubenoff R, Jacques PF, et al: Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: The Framingham Heart Study. J Am Geriatr Soc 51:1237-1243, 2003.
22. Taekema DG, Westendorp RG, Frö lich M, et al: High innate production capacity of tumor necrosis factor-alpha and decline of handgrip strength in old age. Mech Ageing Dev 128:517-521, 2007.
23. Nicklas BJ, Brinkley TE: Exercise training as a treatment for chronic inflammation in the elderly. Exerc Sport Sci Rev 37:165-170, 2009.
24. Penninx BW, Kritchevsky SB, Newman AB, et al: Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 52:1105-1113, 2004.
25. Ferrucci L, Penninx BW, Volpato S, et al: Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 50: 1947-1954, 2002.
26. Collado-Hidalgo A, Bower JE, Ganz PA, et al: Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759-2766, 2006.
27. Asegaonkar SB, Asegaonkar BN, Takalkar UV, et al: C-reactive protein and breast cancer: New insights from old molecule. Int J Breast Cancer 2015: 145647, 2015.
28. Charlson M, Szatrowski TP, Peterson J, et al: Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251, 1994.
29. Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ 2: 217-227, 1993.
30. Tan ZS, Beiser AS, Vasan RS, et al: Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology 68: 1902-1908, 2007.
31. Trompet S, de Craen AJ, Mooijaart S, et al: High innate production capacity of proinflammatory cytokines increases risk for death from cancer: Results of the PROSPER study. Clin Cancer Res 15: 7744-7748, 2009.
32. Kiecolt-Glaser JK, Belury MA, Andridge R, et al: Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: A randomized controlled trial. Brain Behav Immun 26:988-995, 2012.
33. Kenward MG, Roger JH: Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 53:983-997, 1997.
34. Maglinte GA, Hays RD, Kaplan RM: US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol 65:497-502, 2012.
35. Johannesdottir SA, Schmidt M, Phillips G, et al: Use of ß-blockers and mortality following ovarian cancer diagnosis: A population-based cohort study. BMC Cancer 13:85, 2013.
36. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987.
37. Runowicz CD, Leach CR, Henry NL, et al: American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. CA Cancer J Clin 66:43-73, 2016.
38. Runowicz CD, Leach CR, Henry NL, et al: American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol 34:611-635, 2016.